kornik13,
My understanding about U2 was confusion around pressure gradients, fault zones and rapidly changing strata within Alameda-1. The result at Alemada-2 points out that unit 2 is much smaller and wasn't intersected in this well and that structure is far more structurally complex then originally interpreted.
The diagram points out that some of the original Amistad unit 3 was in fact Alameda structure which was high pressure. This explains the original response to the lack of flow in unit 3 and it could have been explained better by the team. They obviously picked it up when they hit Vega Alta and crossed reference to the original well determining the new reservoir parameters.
The end result has been great with a medium/heavy crude that flows to surface across the largest Amistad unit. The company seems happy with the results knowing a material increase in resources is due.
- Forums
- ASX - By Stock
- MAY
- Ann: Alameda-2 - Successful Flow Test of Lighter Oil to Surface
Ann: Alameda-2 - Successful Flow Test of Lighter Oil to Surface, page-336
-
- There are more pages in this discussion • 421 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAY (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.002(8.00%) |
Mkt cap ! $90.99M |
Open | High | Low | Value | Volume |
2.6¢ | 2.8¢ | 2.6¢ | $76.54K | 2.868M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1204500 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 457490 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1204500 | 0.026 |
9 | 2840140 | 0.025 |
10 | 1120626 | 0.024 |
13 | 1198728 | 0.023 |
12 | 4096772 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 457490 | 2 |
0.028 | 921805 | 11 |
0.029 | 1946501 | 9 |
0.030 | 1725234 | 6 |
0.031 | 1082110 | 6 |
Last trade - 10.44am 16/07/2024 (20 minute delay) ? |
Featured News
MAY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online